Distribution of the heterogeneity of des-γ-carboxyprothrombin in patients with hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 10, 2005, Pages 1545-1552

  Uehara, Soichiro ^a   Gotoh, Katsuhiro ^a   Handa, Hiroshi ^a   Tomita, Hiroshi ^a   Senshuu, Mitiko ^a  

^a Dept of Int Med Gastroenterology Ohtakionsen Hospital   (Japan)

Author keywords

Des carboxyprothrombin; Hepatocellular carcinoma; Vitamin K; carboxyglutamic acid

Indexed keywords

4 CARBOXYGLUTAMIC ACID; DECARBOXYPROTHROMBIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 19B7; MONOCLONAL ANTIBODY MU 3; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PROTEIN PRECURSOR; PROTHROMBIN;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC HETEROGENEITY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METASTASIS; MALE; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ACUTE DISEASE; AFFINITY CHROMATOGRAPHY; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; GENETIC VARIABILITY; GENETICS; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; LIVER TUMOR; MIDDLE AGED;

ACUTE DISEASE; ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PROTHROMBIN; VARIATION (GENETICS);

EID: 33644693140     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03899.x     Document Type: Article

References (31)

1. Andrew JB, Ratcliffe JV, Roth DA, Jacob MA, Furie BC, Furie B. Biosynthesis of prothrombin: Intercellular localization of the vitamin K-dependent carboxylase and the sites of γ-carboxylation. Blood 1996 88 : 2585 93.
2. Blanchard RA, Furie BC, Jorgensen M, Kruger SF, Furie B. Acquired vitamin K-dependent carboxylation deficiency in liver disease. N. Engl. J. Med. 1981 305 : 242 8.
3. Blanchard RA, Furie BC, Waneck G, Jorgensen M, Furie B. Immunoassays of human prothrombin species which correlate with functional coagulation activities. J. Lab. Clin. Med. 1983 101 : 242 55.
4. Liebman HA, Furie BC, Tong MJ et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 1984 310 : 1427 31.
5. Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on a carboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985 ii : 242 4.
6. Okuda H, Nakanishi T, Takatsu K et al. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999 85 : 812 18.
7. Shimizu A, Shiraki K, Ito T et al. Sequential fluctuation pattern of serum des-γ-carboxyprothrombin levels detected by high-sensitive electro-chemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Int. J. Mol. Med. 2002 9 : 245 50.
8. Watanabe K, Naraki T, Iwasaki Y. Purification of PIVKA-II from PLC/PRF/5 cell and production of a new monoclonal antibody. Acta Hepatol. Jpn 1994 35 : 192 (In Japanese).
9. Nakao A, Taniguchi K, Inoue S et al. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II found in hepatocellular carcinoma and pancreatobiliary malignancies. Am. J. Gastroenterol. 1997 92 : 1031 4.
10. Sekiya C, Kohda H, Hasebe C, Namiki M, Watanabe K, Naraki T. Characteristics of the PIVKA-II found in hepatocellular carcinoma: Investigation using monoclonal antibodies MU-3 and 19B7. Int. Hepatol. Commun. 1994 2 : 277 84.
11. Ohira M, Ohtake T, Saito H et al. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma. Alcohol. Clin. Exp. Res. 1999 23 : 67S 70S.
12. Malhotra OP. Dicumarol-induced prothrombins. Ann. N. Y. Acad. Sci. 1981 370 : 426 37.
13. Liebman HA. Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy) prothrombin. Cancer Res. 1989 49 : 6493 7.
14. Uehara S, Gotoh K, Handa H, Honjo K, Hirayama A. Process of carboxylation of glutamic acid residues in the Gla domain of human des-γ- carboxyprothrombin. Clin. Chem. Acta 1999 289 : 33 44.
15. Kornalik F, Blömback B. Prothrombin activation induced by a prothrombin converting enzyme from Echis carinatus venom. Thromb. Res. 1975 6 : 53 63.
16. Kuwada M, Katayama K. An improved method for determination of γ-carboxyglutamic acid in proteins, bone and urine. Anal. Biochem. 1983 131 : 173 9.
17. Naraki T, Kohno N, Saito H et al. γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombin. Biochem. Biophys. Acta 2002 1586 : 287 98.
18. Ratcliffe JV, Furie B, Furie BC. The importance of specific γ-carboxyglutamic acid residues in prothrombin. J. Biol. Chem. 1993 268 : 24339 45.
19. Sorciano-Garcia M, Padmanabhan K, de Vos AM, Tullunsky A. The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992 31 : 2554 66.
20. Sugimoto H, Tanaka S, Inoue S, Kaneno T, Watanabe K, Nakao N. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma. Liver Int. 2003 23 : 38 44.
21. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist as a prognostic marker in hepatocellular carcinoma. Cancer 1994 73 : 2364 71.
22. Koike Y, Shiratori Y, Sato S et al. Des-gamma-carboxyprothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma. Cancer 2001 91 : 561 9.
23. Wu W, Suttie JW. N-glycosylation contributes to the intracellular stability of prothrombin precursors in the endoplasmic reticulum. Thromb. Res. 1999 96 : 91 8.
24. Ono M, Ohta H, Ohhira M, Sekiya C, Namiki M. Measurement of immunoreactive prothrombin, and vitamin K in human liver tissues: Overproduction of immunoreactive prothrombin in hepatocellular carcinoma. Am. J. Gastroenterol. 1990 85 : 1149 54.
25. Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxyprothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue. J. Gastroenterol. Hepatol. 1995 10 : 8 13.
26. Huisse MG, Lecleercq M, Belghiti J et al. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinoma. Cancer 1994 74 : 1533 41.
27. Miyakawa T, Kajiwara Y, Shirahata A, Okamoto H, Itoh H, Ohsato K. Vitamin K content in liver tissue of hepatocellular carcinoma patients. Jpn. J. Cancer Res. 2000 91 : 68 74.
28. Brenner BB, Vega BS, Wu SM, Lanir N, Stafford DW, Solera J. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998 92 : 4554 9.
29. Otsuka M, Kato N, Shao RX et al. Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 2004 40 : 243 51.
30. Lefrere JJ, Gozin D, Soulier J et al. Specificity of increases in des-gamma-carboxyprothrombin in hepatocellular carcinoma after K1 injection. J. Hepatol. 1987 5 : 27 9.
31. Gotoh K, Kato S, Sumiya S et al. Urinary levels of γ- carboxyglutamic acid and its clinical significance. Biol. Pharm. Bull. 1994 17 : 142 5.